Spravato is an FDA-approved nasal spray for adults whose depression has not responded to at least two standard antidepressants. Its active ingredient is esketamine, a compound derived from ketamine that works through a completely different brain pathway than traditional antidepressants.
For many people, the initial phases of antidepressants don’t work. For such severe cases, mental health specialists use other options such as Spravato. It is only given in a certified healthcare setting under direct medical supervision. It can reduce symptoms in as little as 24 hours after the first dose.
Table of Contents
What Is Spravato Treatment? Everything You Need to Know
When traditional antidepressants do not provide enough relief, people with treatment-resistant depression may discuss newer treatment options with a qualified mental health professional. Spravato Treatment is one option that has received FDA approval for adults with treatment-resistant depression and is administered as a nasal spray under healthcare supervision.
Unlike conventional antidepressants that primarily affect serotonin, norepinephrine, or dopamine pathways, Spravato contains esketamine and works through the brain’s glutamate system. Because of its different mechanism, Spravato Treatment may offer an alternative for adults whose depression has not improved adequately with standard approaches.
What Is Spravato Treatment?
Spravato Treatment uses Spravato, the brand name for esketamine nasal spray. Esketamine is related to ketamine but is a specific form of the ketamine molecule designed for medical use as a prescription nasal spray.
The FDA-approved labeling includes Spravato Treatment as an option for adults with treatment-resistant depression, either as monotherapy or alongside an oral antidepressant.
Spravato is not a medication that patients simply pick up from a pharmacy and use independently at home. Because of important safety considerations, administration occurs through a certified healthcare setting with appropriate monitoring.
How Does Spravato Work?
Spravato Treatment works differently from many traditional antidepressants. Its active ingredient, esketamine, affects the glutamate system by acting on NMDA receptors. This can influence signaling involving glutamate, an important neurotransmitter in the brain.
Researchers believe changes in glutamate signaling may contribute to improvements in depressive symptoms and changes associated with neural connections. However, individual responses vary, and a mental health professional should determine whether this treatment is appropriate.
The different mechanism is one reason Spravato Treatment has become an important option for people who have not achieved adequate results from conventional antidepressant therapy.
Who May Benefit From Spravato?
Spravato Treatment is primarily considered for adults diagnosed with treatment-resistant depression. Treatment-resistant depression generally refers to depression that has not responded adequately to previous antidepressant treatment.
A clinician will review your psychiatric history, previous medications, current symptoms, medical conditions, medications, and other safety considerations before recommending Spravato Treatment.
The treatment is not appropriate for everyone. Certain medical conditions, medication interactions, or a history of substance misuse may affect whether esketamine is suitable. A professional evaluation is therefore essential before beginning treatment.
What Happens During Spravato Treatment?
A typical Spravato Treatment appointment takes place in a healthcare facility. The patient self-administers the prescribed nasal spray under direct medical supervision rather than receiving the medication without observation.
After administration, the healthcare team monitors the patient for potential side effects. The FDA labeling requires observation for at least two hours after dosing before discharge when the patient is clinically stable.
Patients should arrange transportation because they should not drive or operate machinery after treatment. EM Powerus also states that patients receiving Spravato at its Dartmouth clinic need someone to drive them home afterward.
How Often Is Spravato Given?
The Spravato Treatment schedule depends on the treatment phase and the patient’s response.
According to the FDA prescribing information, treatment for adults with treatment-resistant depression generally begins with twice-weekly administration during Weeks 1 through 4. During Weeks 5 through 8, administration is generally once weekly. From Week 9 onward, dosing may be once weekly or every two weeks, with frequency individualized to maintain response or remission.
A psychiatrist determines the appropriate dose and schedule. Patients should never change the frequency or amount without medical direction.
How Quickly Does Spravato Work?
One reason Spravato Treatment receives attention is its potential for relatively rapid improvement compared with some conventional antidepressant treatments.
However, response varies considerably between individuals. Some patients may notice changes in depressive symptoms relatively early, while others require multiple sessions before meaningful improvement becomes apparent.
Patients should not assume that one dose will immediately resolve depression. The FDA labeling recommends evaluating therapeutic benefit during the induction phase to determine whether continued treatment is appropriate.
What Are the Benefits of Spravato Treatment?
One potential benefit of Spravato Treatment is that it provides another therapeutic pathway for adults whose depression has not responded adequately to previous antidepressants.
Another advantage is the flexibility of the FDA-approved dosing schedule, which can transition from twice-weekly administration during the initial phase to less frequent maintenance treatment when clinically appropriate.
Some patients may also appreciate that Spravato is administered through a nasal spray rather than an injection or an invasive procedure.
Most importantly, Spravato Treatment gives eligible patients another evidence-based option to discuss with a qualified mental health professional when standard depression treatments have not provided sufficient relief.
What Are the Side Effects?
Like any prescription treatment, Spravato Treatment can cause side effects. Commonly reported effects include dissociation, dizziness, nausea, sedation, increased blood pressure, and other temporary sensations.
Dissociation can make a person feel detached from their surroundings or sense of self. This is one reason treatment is administered under medical supervision.
Blood pressure can also temporarily increase following administration. Healthcare professionals monitor patients during the observation period and determine when it is safe to leave.
Because Spravato carries important safety warnings, it should only be used according to the prescribing information and under the supervision of an appropriate certified healthcare provider.
Spravato Treatment in Dartmouth, MA
For people searching for Spravato Treatment in Dartmouth, MA, Boston Neurobehavioral Associates currently offers Spravato at its Dartmouth, Massachusetts location.
The clinic states that its Spravato program is REMS-certified and provides supervised administration with approximately two hours of post-dose monitoring. Its Dartmouth location is listed at 237 State Road, Dartmouth, MA.
This makes Dartmouth a relevant local search market for people looking for Spravato Treatment in Massachusetts, particularly those searching for a Spravato clinic in Dartmouth, MA.
Rather than choosing a provider solely because it appears high in search results, patients should evaluate certification, clinician experience, monitoring procedures, insurance considerations, appointment availability, and whether the treatment is medically appropriate for their individual situation.
Is Spravato Covered by Insurance?
Insurance coverage for Spravato Treatment varies according to the insurer, policy, medical criteria, and authorization requirements.
My Premier MD states that it accepts many major insurance plans and offers insurance verification assistance for its Spravato program.
Patients should confirm their individual benefits, eligibility requirements, copayments, deductibles, and prior authorization requirements before starting treatment.
Is Spravato Right for You?
Spravato Treatment may be worth discussing with a psychiatrist if you have treatment-resistant depression and conventional antidepressant treatments have not provided adequate relief.
It is not a universal solution, and a clinician needs to consider your complete medical and psychiatric history before recommending it. The treatment also requires regular appointments, supervised administration, monitoring, and transportation arrangements after sessions.
For people searching for the best Spravato clinic in Massachusetts, the better approach is to look beyond marketing claims and evaluate whether the clinic follows FDA safety requirements, provides appropriate monitoring, and offers qualified psychiatric care.
Related Article
Final Thoughts
Spravato Treatment has expanded the available options for adults living with treatment-resistant depression. Its esketamine-based nasal spray works differently from conventional antidepressants and is administered under controlled medical supervision.
For eligible patients, Spravato Treatment may provide an additional path when previous depression treatments have not worked sufficiently. However, it should always be considered as part of a professional treatment plan rather than as a self-directed therapy.
If you are considering Spravato Treatment in Dartmouth, MA, speak with a qualified mental health professional about your diagnosis, previous treatments, potential benefits, risks, insurance coverage, and whether esketamine is appropriate for you. TMS Therapy Near Me currently lists its Dartmouth location as its Spravato treatment site in Massachusetts.
Frequently Asked Questions
Q1: How quickly does Spravato start working?
A1: Many patients notice a shift in mood or mental heaviness within hours of their first dose or within the first couple of sessions.
Q2: Can Spravato be the only treatment for depression?
A2: Yes. As of January 2025, the U.S. FDA has approved Spravato (esketamine) nasal spray as a standalone (monotherapy) treatment for adults with treatment‑resistant depression (TRD).
Q3: Does insurance cover Spravato treatment?
A3: Coverage varies by insurer and plan. Many major insurance providers cover Spravato.
Q4: What are the side effects of Spravato?
A4: The most frequently reported side effects include dissociation, dizziness, nausea, sedation, and a feeling of numbness.